Full report

Are microplastics in food a risk factor for obesity? Current evidence, mechanistic pathways and emerging health risks associated with human exposure

The 58-page full report integrates all strands of evidence, including:

  • Environmental and dietary exposure pathways
  • Experimental and mechanistic findings (in vitro and animal models)
  • Human biomonitoring and epidemiological evidence
  • Methodological limitations and uncertainties
  • Public-health relevance and regulatory context

The full report provides the complete analytical framework and is the version of record for this work.

Access: The full report is available as a standalone publication.

 

Component publications (available on request): The report is available in two standalone components (see below): a research-focused analysis and a public health–oriented briefing. The research edition synthesises mechanistic and epidemiological evidence on microplastics and metabolic disruption, while the public health component examines population exposure, health inequalities and regulatory implications, framing microplastics as a potential contributor to the burden of obesity.

 

How to cite this report: CrossChannel Research & Publication Support. Are microplastics in food a risk factor for obesity? Current evidence, mechanistic pathways and emerging health risks associated with human exposure. London: CrossChannel Insights; 2025. doi: 10.65435/crosschannel.sota.2026.001

Research-focused component

Microplastics, Human Exposure Pathways, and Obesity Risk:
An Assessment of Evidence and Outstanding Research Gaps

This 35-page research-focused analysis deals exclusively with the scientific and methodological evidence base, including:

  • Characterisation of microplastic exposure routes
  • Experimental and mechanistic pathways relevant to metabolic health
  • Strengths and limitations of current laboratory and observational studies
  • Key gaps requiring further investigation

This component is intended for researchers, toxicologists, and biomedical scientists.

Availability: Available on request as a standalone component publication.

Public health component

Microplastics and Obesity:
Assessing an Emerging Public Health Risk

This 50-page public-health-focused analysis examines the population-level relevance of microplastic exposure, addressing:

  • Dietary and environmental exposure at population scale
  • Vulnerable populations and exposure inequalities
  • Implications for non-communicable disease prevention
  • Regulatory uncertainty and policy considerations

This component is intended for public-health professionals, policymakers, and regulatory stakeholders.

Availability: Available on request as a standalone component publication.

Selected Reference List

  • Huang H, Wei F, Qiu S, et al. Polystyrene microplastics trigger adiposity in mice by remodelling gut microbiota and boosting fatty acid synthesis. Sci Total Environ. 2023;890:164297. doi:10.1016/j.scitotenv.2023.164297.
  • Hasegawa Y, Okamura T, Ono Y, et al. Oral exposure to high concentrations of polystyrene microplastics alters the intestinal environment and metabolic outcomes in mice. Front Immunol. 2024;15:1407936. doi:10.3389/fimmu.2024.1407936.
  • Okamura T, Hamaguchi M, Hasegawa Y, et al. Oral exposure to polystyrene microplastics of mice on a normal or high-fat diet and intestinal and metabolic outcomes. Environ Health Perspect. 2023 Feb;131(2):27006. doi: 10.1289/EHP11072.
  • Xu M, Niu H, Wu L, et al. Impact of microplastic exposure on blood glucose levels and gut microbiota: differential effects under normal or high-fat diet conditions. Metabolites. 2024;14(9):504. doi:10.3390/metabo14090504.
  • Roh Y, Kim J, Song H, et al. Impact of the oral administration of polystyrene microplastics on hepatic lipid, glucose, and amino acid metabolism in mice. Int J Mol Sci. 2024;25(9):4964. doi:10.3390/ijms25094964.
  • Lv W, Shen Y, Xu S, et al. Underestimated health risks: Dietary restriction magnify the intestinal barrier dysfunction and liver injury in mice induced by polystyrene microplastics. Sci Total Environ. 2023 Nov 10;898:165502. doi: 10.1016/j.scitotenv.2023.165502
  • Kim JE, Sonar NS, Thakuri LS, et al. Mixtures of polystyrene micro and nanoplastics affects fat and glucose metabolism in 3T3-L1 adipocytes and zebrafish larvae. NanoImpact. 2025;37:100549. doi:10.1016/j.impact.2025.100549.
  • Saijo Y, Hasegawa Y, Okamura T, et al. Negative impact of oral exposure to polystyrene microplastics on glucose tolerance and intestinal environment is independent of particle size. Environ Sci Eur. 2025;37:125. doi:10.1186/s12302-025-01158-x.
  • Schwenger KJP, Ghorbani Y, Bharatselvam S, et al. Links between faecal microplastics and parameters related to metabolic dysfunction-associated steatotic liver disease (MASLD) in humans: an exploratory study. Sci Total Environ. 2024;953:176153. doi:10.1016/j.scitotenv.2024.176153.
  • Auguet T, Bertran L, Barrientos-Riosalido A, et al. Are ingested or inhaled microplastics involved in nonalcoholic fatty liver disease? Int J Environ Res Public Health. 2022;19(20):13495. doi:10.3390/ijerph192013495.
  • Kannan K, Vimalkumar K. A review of human exposure to microplastics and insights into microplastics as obesogens. Front Endocrinol (Lausanne). 2021;12:724989. doi:10.3389/fendo.2021.724989.
  • Ullah S, Ahmad S, Guo X, et al. A review of the endocrine disrupting effects of micro and nano plastic and their associated chemicals in mammals. Front Endocrinol (Lausanne). 2023;13:1084236. doi:10.3389/fendo.2022.1084236.
  • Warger J, Lucas M, Lucas A. Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases. Curr Opin Endocrinol Diabetes Obes. 2024;31(2):98–103. doi:10.1097/MED.0000000000000852.
  • Bora SS, Gogoi R, Sharma MR, et al. Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks. Front Cell Infect Microbiol. 2024;14:1492759. doi:10.3389/fcimb.2024.1492759.
  • Thin ZS, Chew J, Ong TYY, et al. Impact of microplastics on the human gut microbiome: a systematic review of microbial composition, diversity, and metabolic disruptions. BMC Gastroenterol. 2025;25:583. doi:10.1186/s12876-025-04140-2.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.